povorcitinib

Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial
Fierce Biotech
Mon, 03/11/24 - 11:52 am
Incyte
clinical trials
prurigo nodularis
povorcitinib
Dupixent
Sanofi
Regeneron
Incyte touts mid-stage data for new JAK inhibitor but stops short of selecting PhIII dose
Endpoints
Tue, 03/21/23 - 10:06 am
AAD
Incyte
JAK inhibitors
povorcitinib
vitiligo
Incyte reports data from Phase IIb vitiligo therapy trial
Clinical Trials Arena
Mon, 03/20/23 - 11:27 am
Incyte
povorcitinib
vitiligo
clinical trials
Incyte reports new data from hidradenitis suppurativa therapy trial
Clinical Trials Arena
Mon, 02/13/23 - 10:25 am
Incyte
clinical trials
hidradenitis suppurativa
povorcitinib